A New Vision Regarding the Competitive Advantages in the Romanian Pharmaceutical Market
Doina Margaritti
Abstract
Doina Margaritti
Abstract
Competition in the pharmaceutical industry assures maximum efficiency regarding the use of a company’s capital in comparison to other competitors that have the same sphere of activity. Creating and maintaining a competitive advantage in the pharmaceutical market is achieved through measures, specific methods that are used by companies in the pharmaceutical industry like planning and production strategies, an efficient use of raw materials, innovative research and development activities and through specializing the work force, thus determining a higher efficiency for the players in this field and an increased efficiency obtained by the competing companies. The new competitive advantage concept is based primary on active, selective policies that are directed to achieve certain targets in the pharmaceutical markets competitiveness, which is focused on four pillars: the company, the competition, the favourable national environment and the adequate economic policies that are oriented and applied to the drug producing companies, the state institutions and the European Union organisations.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Competition in the pharmaceutical industry assures maximum efficiency regarding the use of a company’s capital in comparison to other competitors that have the same sphere of activity. Creating and maintaining a competitive advantage in the pharmaceutical market is achieved through measures, specific methods that are used by companies in the pharmaceutical industry like planning and production strategies, an efficient use of raw materials, innovative research and development activities and through specializing the work force, thus determining a higher efficiency for the players in this field and an increased efficiency obtained by the competing companies. The new competitive advantage concept is based primary on active, selective policies that are directed to achieve certain targets in the pharmaceutical markets competitiveness, which is focused on four pillars: the company, the competition, the favourable national environment and the adequate economic policies that are oriented and applied to the drug producing companies, the state institutions and the European Union organisations.
Key concepts: Competitor analysis, Competition (biology), Industrial organization, Competitive advantage, Pharmaceutical industry, Business, Production (economics), Romanian